The conditional survival statistics for survivors with primary supratentorial astrocytic tumors

被引:22
作者
Hwang, SL
Yang, YHC
Lieu, AS
Chuang, MC
Chang, SJ
Chang, YY
Lin, HJ
Howng, SL
机构
[1] Kaohsiung Med Univ Hosp, Div Neurosurg, Kaohsiung 807, Taiwan
[2] Kaohsiung Med Univ Hosp, Grad Inst Oral Hlth Sci, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ Hosp, Sch Publ Hlth, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan
关键词
survival; conditional probability; astrocytoma; brain tumor;
D O I
10.1023/A:1006484220764
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Relative survival rates can offer a general description of tumor outcome and, traditionally, are used for surveillance and comparison purposes. However, they are not informative for individual tumor survivors. Conditional survival estimates can calculate the probability of surviving next some years given survival to a specific period of time after craniotomy for individual tumor survivors. However, clinically, they have not been used for predicting the tumor outcome. Methods. We calculated conditional probabilities of survival within 6 years after craniotomy in 112 patients with primary supratentorial astrocytic tumors and evaluated factors affecting the survival time more than 2 years after craniotomy. Results. Our data showed that the conditional probability of survival can predict yearly survival rate when patients survive for a specific period of time. The conditional survival rates within 6 years after craniotomy were always higher than those evaluated by relative survival rates. Overall, the longer the patients survived, the higher the conditional probabilities of surviving sixth year postoperatively were. Conclusion. Our study demonstrates the conditional probabilities of survival have good availability and are important estimates for individual tumor survivors.
引用
收藏
页码:257 / 264
页数:8
相关论文
共 29 条
[1]   Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy [J].
Boiardi, A ;
Silvani, A ;
Pozzi, A ;
Farinotti, M ;
Fariselli, L ;
Broggi, G ;
Salmaggi, A .
JOURNAL OF NEURO-ONCOLOGY, 1997, 34 (02) :179-185
[2]   HISTOLOGIC AND NON-HISTOLOGIC FACTORS CORRELATED WITH SURVIVAL-TIME IN SUPRATENTORIAL ASTROCYTIC TUMORS [J].
COHADON, F ;
AOUAD, N ;
ROUGIER, A ;
VITAL, C ;
RIVEL, J ;
DARTIGUES, JF .
JOURNAL OF NEURO-ONCOLOGY, 1985, 3 (02) :105-111
[3]  
COX DR, 1990, ANAL SURVIVAL DATA, P50
[4]   Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991 [J].
Davis, FG ;
Freels, S ;
Grutsch, J ;
Barlas, S ;
Brem, S .
JOURNAL OF NEUROSURGERY, 1998, 88 (01) :1-10
[5]  
Davis FG, 1999, CANCER, V85, P485, DOI 10.1002/(SICI)1097-0142(19990115)85:2<485::AID-CNCR29>3.0.CO
[6]  
2-L
[7]  
Dazzi C, 2000, ANTICANCER RES, V20, P515
[8]  
DUNCAN GG, 1992, J NEURO-ONCOL, V13, P63
[9]   LONG-TERM SURVIVAL IN TREATED ANAPLASTIC ASTROCYTOMAS - A REPORT OF COMBINED RTOG ECOG STUDIES [J].
FISCHBACH, AJ ;
MARTZ, KL ;
NELSON, JS ;
GRIFFIN, TW ;
CHANG, CH ;
HORTON, J ;
NELSON, DF .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (05) :365-370
[10]  
GARJU V, 1994, CANCER, V74, P920